Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Efficacy and safety of hepatitis A vaccination in kidney transplant recipients.

Jeon HJ, Ro H, Jeong JC, Koo TY, Han M, Min SI, Oh KH, Ha J, Ahn C, Yang J.

Transpl Infect Dis. 2014 Jun;16(3):511-5. doi: 10.1111/tid.12217.

PMID:
24750343
2.

Safety and efficacy of hepatitis A vaccination in liver transplantation recipients.

Arslan M, Wiesner RH, Poterucha JJ, Zein NN.

Transplantation. 2001 Jul 27;72(2):272-6.

PMID:
11477352
3.

Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in Switzerland.

Crisinel PA, Posfay-Barbe KM, Aebi C, Cheseaux JJ, Kahlert C, Rudin C, Nadal D, Siegrist CA; Swiss Mother and Child HIV Cohort Study of Switzerland..

Clin Vaccine Immunol. 2012 Nov;19(11):1751-7. doi: 10.1128/CVI.00264-12.

4.
5.

Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease.

Park SH, Yang SK, Park SK, Kim JW, Yang DH, Jung KW, Kim KJ, Ye BD, Byeon JS, Myung SJ, Kim JH.

Inflamm Bowel Dis. 2014 Jan;20(1):69-74. doi: 10.1097/01.MIB.0000437736.91712.a1.

PMID:
24284413
7.

The effects of booster vaccination on combined hepatitis A and hepatitis B vaccine in both anti-HBs and anti-HAV negative children 5-15 years after hepatitis B vaccine primary immunization.

Chen Y, Gu H, Cheng S, Shen L, Cui F, Wang F, Yao J, Xia S, Lv H, Liang X.

Hum Vaccin Immunother. 2013 Apr;9(4):898-902. doi: 10.4161/hv.23193.

8.

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.

Trofa AF, Klein NP, Paul IM, Michaels MG, Goessler M, Chandrasekaran V, Blatter M.

Pediatr Infect Dis J. 2011 Sep;30(9):e164-9. doi: 10.1097/INF.0b013e31821b8a7d.

PMID:
21494175
9.

[Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].

de Artaza Varasa T, Sánchez Ruano JJ, García Vela A, Gómez Rodríguez R, Romero Gutiérrez M, de la Cruz Pérez G, Gómez Moreno AZ, Carrobles Jiménez JM.

Gastroenterol Hepatol. 2009 Aug-Sep;32(7):483-8. doi: 10.1016/j.gastrohep.2009.03.009. Spanish.

PMID:
19577338
10.

Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults.

Tsai IJ, Chang MH, Chen HL, Ni YH, Lee PI, Chiu TY, Safary A.

Vaccine. 2000 Oct 15;19(4-5):437-41.

PMID:
11027806
11.

Hepatitis A vaccine response in HIV-infected patients: are TWINRIX and HAVRIX interchangeable?

Jimenez HR, Hallit RR, Debari VA, Slim J.

Vaccine. 2013 Feb 18;31(9):1328-33. doi: 10.1016/j.vaccine.2012.12.045.

PMID:
23277097
12.

Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.

Gutiérrez Domingo I, Pascasio Acevedo JM, Alcalde Vargas A, Ramos Cuadra A, Ferrer Ríos MT, Sousa Martín JM, Sayago Mota M, Giráldez Gallego A, Suárez Artacho G.

Transplant Proc. 2012 Jul-Aug;44(6):1502-4. doi: 10.1016/j.transproceed.2012.05.020.

PMID:
22841196
13.

Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC study.

Launay O, Grabar S, Gordien E, Desaint C, Jegou D, Abad S, Girard PM, Bélarbi L, Guérin C, Dimet J, Williams V, Krivine A, Salmon D, Lortholary O, Rey D; HEPAVAC Study Group1..

J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):272-5. doi: 10.1097/QAI.0b013e318183a9c0.

PMID:
18845961
14.

Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.

Dhawan PS, Shah SS, Alvares JF, Kher A, Shankaran, Kandoth PW, Sheth PN, Kamath H, Kamath A, Koppikar GV, Kalro RH.

Indian J Gastroenterol. 1998 Jan;17(1):16-8.

PMID:
9465507
15.

Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.

Tseng YT, Chang SY, Liu WC, Sun HY, Wu CH, Wu PY, Lu CL, Hung CC, Chang SC.

Hepatology. 2013 May;57(5):1734-41. doi: 10.1002/hep.26210.

PMID:
23258666
16.
17.

The Seroconversion Rate of Hepatitis A Virus Vaccination among Patients with Hepatitis B Virus-Related Chronic Liver Disease in Korea.

Cho HC, Kim YJ, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.

Gut Liver. 2011 Jun;5(2):217-20. doi: 10.5009/gnl.2011.5.2.217.

18.

Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.

Weinberg A, Gona P, Nachman SA, Defechereux P, Yogev R, Hughes W, Wara D, Spector SA, Read J, Elgie C, Cooper M, Dankner W; Pediatric AIDS Clinical Trials Group 1008 Team..

J Infect Dis. 2006 Jan 15;193(2):302-11.

PMID:
16362896
19.
20.

Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients.

Arguedas MR, Johnson A, Eloubeidi MA, Fallon MB.

Hepatology. 2001 Jul;34(1):28-31.

PMID:
11431730
Items per page

Supplemental Content

Support Center